Conviction
$ Value
$4.0M
Shares
200
Price
$20K
Filed
Jun 17
▶ Why this score? (7/10)
- ✓ Open market buy (+3)
- ✓ Trade value >= $1.0M (+2)
- ✓ Director (+1)
- ✓ Not a 10b5-1 plan (+1)
Insider
Name
DUNTON ALAN W
Title
—
CIK
0001304773
Roles
Transaction Details
Transaction Date
2025-06-13
Code
P
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
224,112
Footnotes
Each share of Series D Convertible Preferred Stock has a stated value of $100 per share, and is convertible to common stock at an initial conversion price of $0.11 per share, for a total of 181,818 shares of common stock. The Series D Preferred Stock and Series I common stock purchase warrants were sold at a combined offering price of $0.11 per share of common stock obtainable upon conversion of the Series D Convertible Preferred Stock. | The Series I warrants are exercisable on or after the date that approval is obtained from the Issuer's stockholders as may be required by the NYSE American (or any successor entity) (the "Stockholder Approval Date"), and will expire on the five-year anniversary of the Stockholder Approval Date, subject to the terms and conditions contained in such Series I warrant.
Filing Info
DUNTON ALAN W's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-01-26 | CRMD | A | $0 |
| 2025-12-30 | CRMD | M | $81K |
| 2025-12-30 | CRMD | ▼ | $260K |
| 2025-12-30 | CRMD | M | $0 |
| 2025-12-11 | OGEN | A | $0 |
| 2025-12-09 | PTN | A | $0 |
| 2025-12-09 | PTN | A | $0 |
| 2025-12-09 | PTN | A | $0 |
| 2025-12-09 | PTN | A | $0 |
| 2025-09-12 | CRMD | M | $36K |
Other Insiders at PTN (90d)
No other insider activity at this issuer in the last 90 days.